title: Theoretical Study of the Mechanism of Exemestane Hydroxylation Catalyzed by Human Aromatase Enzyme.
abstract: Human aromatase (CYP19A1) aromatizes the androgens to form estrogens via a three-step oxidative process. The estrogens are necessary in humans, mainly in women, because of the role they play in sexual and reproductive development. However, these also are involved in the development and growth of hormone-dependent breast cancer. Therefore, inhibition of the enzyme aromatase, by means of drugs known as aromatase inhibitors, is the frontline therapy for these types of cancers. Exemestane is a suicidal third-generation inhibitor of aromatase, currently used in breast cancer treatment. In this study, the hydroxylation of exemestane catalyzed by aromatase has been studied by means of hybrid QM/MM methods. The Free Energy Perturbation calculations provided a free energy of activation for the hydrogen abstraction step (rate-limiting step) of 17 kcal/mol. The results reveal that the hydroxylation of exemestane is not the inhibition stage, suggesting a possible competitive mechanism between the inhibitor and the natural substrate androstenedione in the first catalytic subcycle of the enzyme. Furthermore, the analysis of the interaction energy for the substrate and the cofactor in the active site shows that the role of the enzymatic environment during this reaction consists of a transition state stabilization by means of electrostatic effects.
authors.affiliation: Departament de Química Física i Analítica, Universitat Jaume I , 12071 Castelló, Spain.
authors.forename: Ignacio
authors.initials: I
authors.lastname: Viciano
authors.affiliation: Departament de Química Física i Analítica, Universitat Jaume I , 12071 Castelló, Spain.
authors.forename: Sergio
authors.initials: S
authors.lastname: Martí
mesh_terms: D000730:Androstadienes / Q000494:pharmacology*; D000735:Androstenedione / Q000378:metabolism; D001141:Aromatase / Q000378:metabolism*; D047072:Aromatase Inhibitors / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000201:enzymology / Q000378:metabolism; D005260:Female; D006801:Humans; D006900:Hydroxylation / Q000187:drug effects; D062105:Molecular Docking Simulation; D013816:Thermodynamics
chemical_list: D000730:Androstadienes; D047072:Aromatase Inhibitors; D000735:Androstenedione; D001141:Aromatase; C561410:CYP19A1 protein, human; C056516:exemestane